11%
Amplivox Model 270 Two-Channel Diagnostic Audiometer
Amplivox Model 270 Two-Channel Diagnostic Audiometer. A two-channel diagnostic audiometer which provides an extensive range of measurements for diagnostic audiology and hearing aid fitting.
Original price was: £3,535.73.£3,156.90Current price is: £3,156.90.
Additional information
Amplivox Model 270 Two-Channel Diagnostic Audiometer
A two-channel diagnostic audiometer which provides an extensive range of measurements for diagnostic audiology and hearing aid fitting. Benefiting from an ergonomic design and logical key layout, hearing tests can be conducted quickly and efficiently.
Including air conduction (AC), bone conduction (BC) and speech testing, the Model 270 is ideal for audiology specialists and hearing health experts who operate within a clinic, workplace, or on-the-go.
Test options
This portable audiometer features everything you’d expect for both screening and diagnostic audiometry. With manual air and bone conduction testing, alongside helpful assistance tools, operators can determine hearing loss issues quickly and efficiently.
With recorded and live speech testing, the SRT and SDT score can be defined easily at the most comfortable threshold level (MCL) for faster hearing aid fitting. The Model 270 also includes clinical tests such as Stenger, ABLB and SISI ensuring that class leading patient care can be provided. Learn how to set-up and use the Model 270 in less than 3 minutes:
Key features
- Two-channel audiometry
- Frequency range (AC): 125 - 8000Hz
- Attenuation range (AC): -10 - 120dBHL
- Air and bone conduction with masking
- THL, MCL, ULL/UCL
- Speech testing (live and recorded)
- Free field audiometry (2 speakers)
- Special tests: ABLB, Stenger, SISI
- Third-party EMR connectivity
- Compact, lightweight and portable
Accessories for use with Amplivox Model 270 Two-Channel Diagnostic Audiometer
We also recommend
Supplying Medical Equipment to the NHS for over 20 years
With excellent service and after sale support. Please dont hesitate to contact us.

























